Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The market for polymerase chain reaction (PCR) devices, reagents, and their applications has experienced significant growth in recent years. This expansion reflects the increasing importance of these technologies in diverse fields such as diagnostics, research, and personalized medicine. Let’s explore the current market size, key drivers behind growth, important segments, leading companies, and regional developments shaping this industry.
Market Expansion and Forecast for the Polymerase Chain Reaction Devices, Reagents and Uses Market
The PCR devices, reagents, and uses market is on an upward trajectory, with projections showing growth from $6.51 billion in 2025 to $6.97 billion in 2026, representing a compound annual growth rate (CAGR) of 7.2%. This positive trend stems from factors such as outbreaks of infectious diseases, growth in genomics research, increased clinical diagnostic laboratories, demand for COVID-19 testing, and broader adoption of molecular biology techniques. Looking further ahead, the market is expected to reach $9.84 billion by 2030, growing at a faster CAGR of 9.0%. This anticipated boost is fueled by rising personalized medicine practices, expanding cancer diagnostics, wider genetic screening, enhanced research funding, and growing demand for rapid diagnostic solutions. Key trends shaping the market include the surge in molecular diagnostics, expanded infectious disease testing, greater use of real-time PCR, intensified research-based PCR applications, and the miniaturization of PCR instruments.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2485&type=smp
How Infectious Diseases Are Propelling Market Growth in PCR Devices, Reagents and Uses
The increasing incidence of infectious diseases is a major driver for the PCR devices and reagents market. These diseases, caused by pathogens like bacteria, viruses, fungi, or parasites, spread through direct or indirect contact among individuals. The rise in global travel has accelerated the transmission of such diseases across borders, highlighting the need for rapid and accurate diagnostic tools. PCR technologies play a crucial role in this context by amplifying genetic material to quickly identify infections and improve laboratory efficiency. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England rose by 10.7% in 2023 compared to 2022, reaching 4,850 cases. This growing prevalence underscores the importance of PCR methods in disease management and supports market growth.
Additional Factors Supporting the Expansion of the PCR Devices, Reagents and Uses Market
Beyond infectious diseases, the adoption of PCR technologies is increasing due to broader applications in clinical diagnostics, pharmaceutical development, and biotechnology. The demand for faster, more reliable genetic testing methods is driving investments and innovations in PCR platforms. Laboratories and research organizations are embracing these tools to enhance accuracy and speed, addressing needs from early disease detection to environmental monitoring and food safety testing.
Access The Complete Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Report:
Breakdown of Market Segments Within PCR Devices, Reagents and Uses
The PCR market can be divided into several key segments for better understanding:
1) By Product Type: Instruments, Reagents, Consumables
2) By Instrument Category: Standard PCR, RT-PCR, Digital PCR
3) By End Users: Pharmaceutical and Biotechnology Industries, Clinical Diagnostics Labs and Hospitals, Academic and Research Organizations
Further subcategories include types of instruments such as thermal cyclers, real-time PCR systems, and digital PCR systems. Reagents are classified into master mixes, primers and probes, enzymes, and nucleotides. Consumables include PCR tubes, PCR plates, seals and films, and pipette tips. This detailed segmentation reflects the wide range of products necessary to support diverse PCR applications.
Innovations and Market Trends Shaping the Future of PCR Devices and Reagents
Leading companies in the PCR market are prioritizing the development of cutting-edge diagnostic tools that enhance the precision and speed of genetic testing. These advancements improve early detection of diseases and support a broad array of research efforts spanning healthcare, environmental studies, and food safety. For example, in August 2023, Germany-based Gold Standard Diagnostics launched DNAllergen RT-PCR kits designed for highly sensitive detection of specific allergens in food products. These kits utilize real-time PCR technology to identify allergens like almond, celery, and fish with improved accuracy, addressing challenges that traditional testing methods face.
Competitive Landscape and Major Players in the PCR Devices, Reagents and Uses Market
Key industry leaders dominating the PCR space include Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH, Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, and GenMark Diagnostics Inc. These companies focus on product innovation, strategic collaborations, and expanding their market reach.
Geographical Breakdown and Regional Market Development for PCR Devices and Reagents
In 2025, North America was the largest market for PCR devices and reagents, reflecting established healthcare infrastructure and strong research capabilities. Western Europe ranked as the second-largest region globally. The analysis also covers regions such as Asia-Pacific, South East Asia, Eastern Europe, South America, Middle East, and Africa, highlighting global market dynamics and opportunities for expansion across different geographies.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
